A phase 2, randomized, placebo-controlled, double-blind, ascending dose study to evaluate efficacy, safety, tolerability, pharmacokinetics, pharmacodynamics & pharmacogenetics of CC-220 in subjects with SLE

被引：0
|
作者：
Werth, V. [1 ]
Furie, R. [2 ]
Hough, D. [3 ]
Korish, S. [3 ]
Weiswasser, M. [3 ]
Azarian, A. [3 ]
Schafer, P. [3 ]
Delev, N. [3 ]
Choi, S. [3 ]
机构：
[1] UPenn, Philadelphia, PA USA
[2] Northwell Hlth, Great Neck, NY USA
[3] Celgene, Summit, NJ USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2017年 / 137卷 / 05期
关键词：
D O I：
10.1016/j.jid.2017.02.396
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
379
引用
收藏
页码：S65 / S65
页数：1
相关论文
共 50 条
  • [1] A PHASE 2, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, ASCENDING DOSE STUDY TO EVALUATE EFFICACY, SAFETY, AND TOLERABILITY OF CC 220 IN SUBJECTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Furie, R.
    Werth, V. P.
    Lee, E.
    Box, E.
    Fondal, M.
    Kivitz, A.
    Chatham, W. W.
    Kalunian, K. C.
    Legerton, C.
    Anolik, J. H.
    Korish, S.
    Hough, D. R.
    Weiswasser, M.
    Choi, S.
    Schafer, P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : S77 - S77
  • [2] A Randomized, Placebo-Controlled, Double-Blind, Ascending-Dose, Safety, and Pharmacokinetics Study of CC-220 in Subjects with Systemic LUPUS Erythematosus
    Furie, Richard
    Werth, Victoria P.
    Gaudy, Allison
    Ye, Ying
    Korish, Shimon
    Azaryan, Ada
    Delev, Nikolay
    Hough, Douglas
    Weiswasser, Michael
    Choi, Suktae
    Schafer, Peter
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [3] A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, ASCENDING-DOSE, SAFETY STUDY OF CC-220 IN SUBJECTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Werth, V. P.
    Furie, R.
    Korish, S.
    Weiswasser, M.
    Azaryan, A.
    Schafer, P. H.
    Delev, N.
    Choi, S.
    Hough, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 870 - 871
  • [4] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alirocumab in Healthy Chinese Subjects: A Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study
    Haiyan Li
    Yudong Wei
    Zhenhua Yang
    Shuang Zhang
    Xiuxiu Xu
    Mengmeng Shuai
    Olivier Vitse
    Yiwen Wu
    Marie T. Baccara-Dinet
    Yi Zhang
    Jianyong Li
    American Journal of Cardiovascular Drugs, 2020, 20 : 489 - 503
  • [5] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alirocumab in Healthy Chinese Subjects: A Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study
    Li, Haiyan
    Wei, Yudong
    Yang, Zhenhua
    Zhang, Shuang
    Xu, Xiuxiu
    Shuai, Mengmeng
    Vitse, Olivier
    Wu, Yiwen
    Baccara-Dinet, Marie T.
    Zhang, Yi
    Li, Jianyong
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2020, 20 (05) : 489 - 503
  • [6] A randomized, double-blind, placebo-controlled, single ascending dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of CBP-201 administered to healthy adult subjects
    Royal, Mike A.
    White, Jeffery
    Snyder, Ben
    Wei, Zheng
    Pan, Wubin
    Wang, Junying
    Sansone, Kenneth J.
    Yang, Xin
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB159 - AB159
  • [7] A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability and Pharmacodynamics of AMG145
    Dias, Clapton
    Shaywitz, Adam
    Smith, Brian
    Emery, Maurice
    Bing, Gao
    Gibbs, John
    Wishner, Bill
    Stolman, Dina
    Crispino, Caroline
    Crispino, Caroline
    Cook, Blaire
    Colbert, Alex
    Retter, Marc
    Xu, Ren
    Matson, Mark
    CIRCULATION, 2011, 124 (21)
  • [8] A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Ascending Multiple Oral Doses of CC 930 in Healthy Volunteers
    Kong, Linghui
    Ye, Ying
    Liu, Liangang
    Reyes, Josephine
    Wan, Yuntao
    Wu, Anfan
    Lau, Henry
    Laskin, Oscar
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (09): : 1343 - 1343
  • [9] A Double-blind, Placebo-controlled, Randomized, Single Ascending, and Multiple Dose Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Dose Isomyosamine Capsules in Healthy Adult Subjects
    Brager, Jenna
    Chapman, Chris
    Dunn, Leonard
    Kaplin, Adam
    DRUG RESEARCH, 2023, 73 (02) : 95 - 104
  • [10] A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, EFFICACY, PHARMACOKINETICS AND PHARMACODYNAMICS OF NIPOCALIMAB (M281) IN ADULTS WITH GE
    Guptill, Jeffrey
    Antozzi, Carlo
    Bril, Vera
    Gamez, Josep
    Meuth, Sven
    Munoz Blanco, Jose Luis
    Nowak, Richard
    Quan, Dianna
    Sevilla, Teresa
    Szczudlik, Andrzej
    Hegarty, Brooke
    Jouvin, Marie-Helene
    Jin, Jim
    Arroyo, Santiago
    MUSCLE & NERVE, 2020, 62 : S88 - S88
12345